Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis.
- DOI
- 10.14309/ctg.0000000000000462
- Published
- 2022 Feb 9
- Container
- Clinical and translational gastroenterology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.14309/ctg.0000000000000462,
title = {Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis.},
author = {Innes H and Walker AJ and Benselin J and Grove JI and Pedergnana V and Azim Ansari M and Lin SK and McLauchlan J and Hutchinson SJ and Barnes E and Irving WL and Guha IN and on behalf of the HCV Research UK and \& STOP-HCV and Consortia},
year = {2022},
journal = {Clinical and translational gastroenterology},
doi = {10.14309/ctg.0000000000000462},
url = {https://doi.org/10.14309/ctg.0000000000000462}
}RIS
TY - JOUR TI - Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis. AU - Innes H AU - Walker AJ AU - Benselin J AU - Grove JI AU - Pedergnana V AU - Azim Ansari M AU - Lin SK AU - McLauchlan J AU - Hutchinson SJ AU - Barnes E AU - Irving WL AU - Guha IN AU - on behalf of the HCV Research UK AU - & STOP-HCV AU - Consortia PY - 2022 JO - Clinical and translational gastroenterology DO - 10.14309/ctg.0000000000000462 UR - https://doi.org/10.14309/ctg.0000000000000462 ER -
APA
H, I., AJ, W., J, B., JI, G., V, P., M, A. A., SK, L., J, M., SJ, H., E, B., WL, I., IN, G., UK, O. B. O. T. H. R., STOP-HCV, &., & Consortia (2022). Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis.. Clinical and translational gastroenterology. https://doi.org/10.14309/ctg.0000000000000462
Source records
- pubmed · retrieved 2026-09-27T12:28:05.367Z